Victory Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$114M Buy
396,655
+150,296
+61% +$43.2M 0.07% 263
2025
Q1
$75.9M Buy
246,359
+52,951
+27% +$16.3M 0.08% 306
2024
Q4
$68.2M Buy
193,408
+6,589
+4% +$2.32M 0.07% 344
2024
Q3
$66.9M Buy
186,819
+33,599
+22% +$12M 0.06% 372
2024
Q2
$48.8M Buy
153,220
+8,116
+6% +$2.59M 0.05% 455
2024
Q1
$33.3M Buy
145,104
+10,942
+8% +$2.51M 0.03% 626
2023
Q4
$29.5M Buy
134,162
+101,419
+310% +$22.3M 0.03% 631
2023
Q3
$7.4M Buy
32,743
+10,140
+45% +$2.29M 0.01% 1125
2023
Q2
$4.99M Sell
22,603
-5,958
-21% -$1.32M 0.01% 1206
2023
Q1
$6.4M Sell
28,561
-110
-0.4% -$24.6K 0.01% 1155
2022
Q4
$7.97M Buy
28,671
+7,046
+33% +$1.96M 0.01% 1093
2022
Q3
$4.53M Buy
21,625
+5,693
+36% +$1.19M 0.01% 1270
2022
Q2
$3.75M Buy
15,932
+58
+0.4% +$13.7K ﹤0.01% 1307
2022
Q1
$2.82M Buy
15,874
+3,901
+33% +$693K ﹤0.01% 1399
2021
Q4
$2.59M Sell
11,973
-499
-4% -$108K ﹤0.01% 1477
2021
Q3
$2.3M Sell
12,472
-863
-6% -$159K ﹤0.01% 1558
2021
Q2
$2.39M Sell
13,335
-1,817
-12% -$326K ﹤0.01% 1579
2021
Q1
$2.53M Sell
15,152
-646
-4% -$108K ﹤0.01% 1578
2020
Q4
$2.4M Sell
15,798
-4,433
-22% -$673K ﹤0.01% 1468
2020
Q3
$2.04M Sell
20,231
-366
-2% -$37K ﹤0.01% 1436
2020
Q2
$2.49M Sell
20,597
-24,711
-55% -$2.99M ﹤0.01% 1366
2020
Q1
$4.3M Buy
45,308
+34,815
+332% +$3.3M ﹤0.01% 1314
2019
Q4
$924K Buy
10,493
+304
+3% +$26.8K ﹤0.01% 1778
2019
Q3
$813K Sell
10,189
-22,439
-69% -$1.79M ﹤0.01% 1741
2019
Q2
$2.55M Buy
32,628
+9,266
+40% +$723K 0.01% 1079
2019
Q1
$2.74M Buy
23,362
+1,425
+6% +$167K 0.01% 1016
2018
Q4
$2.39M Sell
21,937
-84
-0.4% -$9.15K 0.01% 994
2018
Q3
$2.82M Buy
+22,021
New +$2.82M 0.01% 1024
2017
Q3
Sell
-6,549
Closed -$850K 1874
2017
Q2
$850K Buy
6,549
+1,133
+21% +$147K ﹤0.01% 1223
2017
Q1
$733K Buy
5,416
+432
+9% +$58.5K ﹤0.01% 1238
2016
Q4
$715K Buy
4,984
+589
+13% +$84.5K ﹤0.01% 1209
2016
Q3
$519K Buy
+4,395
New +$519K ﹤0.01% 1242